Announcements Trials
Browse Landscape

Phase

Phase 2 59Phase 1 21Phase NA 15Phase 3 11Phase 1/2 10Phase EARLY_PHASE1 3Phase 4 2Phase 2/3 2

Status

Completed 11Unknown 10Active not recruiting 8Recruiting 4Terminated 3Not yet recruiting 3Withdrawn 1Enrolling by invitation 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 32CNS 28Lymphoid 23Thoracic 19Breast 18Genitourinary 17Head & Neck 16Dermatologic 15Other hematologic neoplasm 14Gynecologic 13Sarcoma 9Other solid neoplasm 8Tumor-Agnostic 6Plasma cell 6Endocrine 3NET 2Myeloid 2Other neoplasm 1Classical hematology 1

Conditions

Neuroendocrine Tumors 2von Hippel-Lindau Disease 1Multiple Endocrine Neoplasia Type 1 1Meningioma 1Lung Neoplasms 1Kidney Neoplasms 1Breast Neoplasms 1Adrenal Gland Neoplasms 1

Interventions

gallium Ga 68 dotatate 1Magnetic Resonance Spectroscopy 190Y-octreotide, DOTA-Tyr(3)- 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Terminated × Endocrine × Clear all
NCT03724409 2023-11-28

Selective Intra-arterial Injection of PRRT in Neuroendocrine Tumor Patients With Liver Metastases

University of Iowa

Phase EARLY_PHASE1 Terminated
3 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT03001349 2021-02-15

68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Terminated
4 enrolled
CNSEndocrineNET

von Hippel-Lindau Disease, Meningioma, Neuroendocrine Tumors, Multiple Endocrine Neoplasia Type 1

NCT01086696 2019-12-17

A Pilot Study of F-18 Paclitaxel (FPAC) PET for Evaluating Drug Delivery of Solid Tumors in Breast, Lung, Renal, and Adrenal Cancers

National Institutes of Health Clinical Center (CC)

Phase EARLY_PHASE1 Terminated
6 enrolled
BreastEndocrineGenitourinaryThoracic

Adrenal Gland Neoplasms, Breast Neoplasms, Kidney Neoplasms, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡